Research Analysts’ Weekly Ratings Updates for McKesson (MCK)

A number of firms have modified their ratings and price targets on shares of McKesson (NYSE: MCK) recently:

• 11/25/2025 – McKesson had its “buy (a-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – McKesson was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 11/19/2025 – McKesson was upgraded by analysts at Weiss Ratings from a “buy (b+)” rating to a “buy (a-)” rating.
• 11/13/2025 – McKesson had its “buy (b+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/10/2025 – McKesson had its price target raised by analysts at Wells Fargo & Company from $816.00 to $914.00. They now have an “equal weight” rating on the stock.
• 11/8/2025 – McKesson was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/6/2025 – McKesson had its “outperform” rating reaffirmed by analysts at Evercore ISI. They now have a $1,000.00 price target on the stock.
• 11/6/2025 – McKesson had its price target raised by analysts at Robert W. Baird from $873.00 to $927.00. They now have an “outperform” rating on the stock.
• 11/6/2025 – McKesson had its price target raised by analysts at UBS Group AG from $920.00 to $980.00. They now have a “buy” rating on the stock.
• 11/6/2025 – McKesson had its price target raised by analysts at Morgan Stanley from $857.00 to $916.00. They now have an “overweight” rating on the stock.
• 10/27/2025 – McKesson had its price target raised by analysts at UBS Group AG from $860.00 to $920.00. They now have a “buy” rating on the stock.
• 10/27/2025 – McKesson was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 10/13/2025 – McKesson had its price target raised by analysts at Jefferies Financial Group Inc. from $820.00 to $900.00. They now have a “buy” rating on the stock.
• 10/8/2025 – McKesson had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a $0.82 dividend. The ex-dividend date is Monday, December 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is 10.21%.

Insiders Place Their Bets

In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm’s stock in a transaction dated Friday, November 7th. The stock was sold at an average price of $861.63, for a total transaction of $283,476.27. Following the completion of the sale, the chief accounting officer directly owned 328 shares of the company’s stock, valued at $282,614.64. This trade represents a 50.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.08% of the stock is currently owned by insiders.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.